MXPA03004675A - Moleculas relacionadas con factor del crecimiento transformador-beta y uso de las mismas. - Google Patents

Moleculas relacionadas con factor del crecimiento transformador-beta y uso de las mismas.

Info

Publication number
MXPA03004675A
MXPA03004675A MXPA03004675A MXPA03004675A MXPA03004675A MX PA03004675 A MXPA03004675 A MX PA03004675A MX PA03004675 A MXPA03004675 A MX PA03004675A MX PA03004675 A MXPA03004675 A MX PA03004675A MX PA03004675 A MXPA03004675 A MX PA03004675A
Authority
MX
Mexico
Prior art keywords
beta
growth factor
transforming growth
related molecules
molecules
Prior art date
Application number
MXPA03004675A
Other languages
English (en)
Spanish (es)
Inventor
Shuqian Jing
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of MXPA03004675A publication Critical patent/MXPA03004675A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MXPA03004675A 2000-11-28 2001-11-28 Moleculas relacionadas con factor del crecimiento transformador-beta y uso de las mismas. MXPA03004675A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25347600P 2000-11-28 2000-11-28
PCT/US2001/044866 WO2002044379A2 (en) 2000-11-28 2001-11-28 Transforming growth factor-beta-related molecules and uses thereof

Publications (1)

Publication Number Publication Date
MXPA03004675A true MXPA03004675A (es) 2003-09-05

Family

ID=22960431

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03004675A MXPA03004675A (es) 2000-11-28 2001-11-28 Moleculas relacionadas con factor del crecimiento transformador-beta y uso de las mismas.

Country Status (7)

Country Link
US (2) US20020151695A1 (enExample)
EP (1) EP1339847A2 (enExample)
JP (1) JP2004514448A (enExample)
AU (1) AU2002219947A1 (enExample)
CA (1) CA2430257A1 (enExample)
MX (1) MXPA03004675A (enExample)
WO (1) WO2002044379A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030170631A1 (en) * 2000-04-03 2003-09-11 Corixa Corporation Methods, compositions and kits for the detection and monitoring of breast cancer
AU2002318513A1 (en) * 2001-07-06 2003-01-21 Nsgene A/S Novel neurotrophic factors
EP2290088A1 (en) * 2004-12-22 2011-03-02 Genentech, Inc. Methods for producing soluble multi-menbrane-spanning proteins

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0323842A3 (en) * 1988-01-07 1990-04-25 Otsuka Pharmaceutical Co., Ltd. Method of purification of transforming growth factor-beta
GB9601081D0 (en) * 1995-10-06 1996-03-20 Cambridge Antibody Tech Specific binding members for human transforming growth factor beta;materials and methods
IL141869A0 (en) * 1998-09-17 2002-03-10 Zymogenetics Inc Mammalian transforming growth factor beta-9 (ztgfss9)
ID30316A (id) * 1999-04-09 2001-11-22 Hanmi Pharma Co Ltd METODE UNTUK MENGHITUNG FAKTOR-β1 PERUBAHAN PERTUMBUHAN DAN METODE UNTUK MENDETEKSI KANKER DENGAN FAKTOR-β1 PERUBAHAN PERTUMBUHAN
AU2001256964A1 (en) * 2000-03-24 2001-10-08 Smith Kline Beecham Corporation Novel compounds
CA2407449A1 (en) * 2000-04-27 2001-11-01 Smithkline Beecham Corporation Novel compounds
WO2001092305A2 (en) * 2000-05-31 2001-12-06 Zymogenetics, Inc. Mammalian transforming growth factor beta-10
ATE549347T1 (de) * 2000-09-08 2012-03-15 Schering Corp Gene von säugetiere, und damit verbundene reagentien, methoden

Also Published As

Publication number Publication date
AU2002219947A1 (en) 2002-06-11
EP1339847A2 (en) 2003-09-03
CA2430257A1 (en) 2002-06-06
JP2004514448A (ja) 2004-05-20
WO2002044379A3 (en) 2003-03-13
US20060281149A1 (en) 2006-12-14
WO2002044379A2 (en) 2002-06-06
US20020151695A1 (en) 2002-10-17

Similar Documents

Publication Publication Date Title
MXPA02012749A (es) Moleculas semejantes a b7 y sus usos.
AU2002235128A1 (en) Expression miniarrays and uses thereof
EP1247815A3 (en) Modified oligonucleotides and uses thereof
AU2002221749A1 (en) Synthetic viruses and uses thereof
AU2001213236A1 (en) Mini-cyclone biocollector and concentrator
AU2001267897A1 (en) Hair design system and its applications
MXPA03004016A (es) Pirrolcarboxamidas y pirrolcarbotioamidas y sus usos agroquimicos.
AU2002214629A1 (en) Non-metallic bioreactor and uses
AU2001271744A1 (en) Leucine-rich repeat proteins, zlrr7, zlrr8 and zlrr9
AU7296801A (en) Il-17 molecules and uses thereof
AU5720601A (en) Bispecific molecules and uses thereof
AU4196801A (en) Chordin-like-2 molecules and uses thereof
AU2001215798A1 (en) Click-to-add, jot-it-down, and add banner
AU2001240637A1 (en) Novel imidazotriazinones and the use thereof
AU2002219135A1 (en) Substituted 2-anilino-benzimidazoles and the use thereof as NHE-inhibitors
AU2002211717A1 (en) Stresscopins and their uses
AU2001291132A1 (en) Lymphoma associated molecules and uses therefor
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU2001264852A1 (en) Lactobacillusbeta -glucuronidase and dna encoding the same
AU2001266939A1 (en) Biocidal polyamides and methods
AU2001275990A1 (en) 16816 and 16839, novel human phospholipase c molecules and uses therefor
AU2001263492A1 (en) 21956 and 25856, human aminopeptidases and uses thereof
AU2002327945A1 (en) Human delta-n p73 molecules and uses thereof
AU2001271400A1 (en) Bioelastomer nanomachines and biosensors